Should You Buy Pfizer Stock Ahead of Its Q2 Results?

Core Insights - Pfizer is scheduled to announce its earnings on August 5, 2025, with historical trends indicating a positive stock movement post-announcement [2][3] - The consensus forecast for the upcoming quarter is earnings of $0.58 per share on sales of $13.53 billion, compared to $0.60 per share on sales of $13.28 billion in the same quarter last year [3] - Pfizer's current market capitalization is $132 billion, with $62 billion in revenue, $15 billion in operating profits, and a net income of $7.9 billion over the last twelve months [4] Historical Performance - Over the past five years, Pfizer has recorded 19 earnings data points, with 10 positive and 9 negative one-day returns, resulting in a 53% occurrence of positive returns [7] - The median positive return is 3.2%, while the median negative return is -1.4% [7] - The percentage of positive returns increases to 55% when considering the last three years [7] Trading Strategies - Event-driven traders can benefit from understanding historical trends and positioning themselves accordingly before and after earnings announcements [6][8] - A strategy involving correlation between short-term and medium-term returns can be employed, particularly if 1D and 5D returns show high correlation [8] - Peer performance may influence stock reactions post-earnings, with historical data indicating that pricing can begin before the earnings announcement [9]